You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The authors from King Faisal Specialist Hospital and Research Center aim to implement exome sequencing as a routine clinical test for male infertility patients.
The team sequenced more than 2,200 Saudi families to find the likely source of genetic disease in about 43 percent of cases.
Targeted sequencing on isolates collected in Saudi Arabia led to 16 rare, non-tuberculosis Mycobacterium species from individuals with lung or other infections.
In a cohort of some 300 people with intellectual disability, a genomic approach offered a likely diagnosis some 60 percent of the time.
Along with known contributors to thyroid cancer, researchers detected mutations that were associated with aggressive cases and metastasis.
The Saudi Arabian research team analyzed the autozygomes and exomes of 31 families and found a strong candidate variant in 90 percent of them.
Researchers in Saudi Arabia sequenced the exomes of women having trouble conceiving and found a mutation that appears to halt early embryonic development.
Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.
A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.
In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.
According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.